Sunnyvale, CA – JSR Micro, Inc. announced that it has expanded the JSR Life Sciences business division by becoming the majority shareholder of Boston area-based MBL International Corporation (MBLI). Tim Lowery, Sr. Vice President of Emerging Technologies at JSR Micro, Inc., has been appointed as the Chief Executive Officer of MBLI effective immediately. MBLI is […]
MANASSAS, Va., — ATCC, a global leader in biological materials management and standards, today announced two executive leadership appointments to help drive new business growth and build ATCC’s brand in a dynamic and competitive environment. Dr. Scott Siegel joins ATCC as Vice President, Corporate Development, and Ms. Melissa Parker joins as Director, Corporate Communications and […]
Siegenburg, Germany, – Wagner Medizin-und Pharmatechnik GmbH & Co. KG (WMPT), Siegenburg, Germany announced the company has acquired rights to the total shares of Redd & Whyte Limited (RW), Bury St Edmunds, UK as part of a multi-year strategic partnership agreement. Effective immediately WMPT will take direct responsibility for all customer facing activities including sales, […]
CAMBRIDGE, Mass., and SEATTLE – Gen9 and Arzeda announced an agreement for the supply of megabase quantities of synthetic DNA that will enable Arzeda to accelerate development of novel molecules for its own products as well as those of its partners. The collaboration is part of Gen9’s Multiplex Access Partnership (MAP) program, designed to provide […]
Sengenics Announces Commercial Partnership with RayBiotech for its Immunome Protein Array Technology
Sengenics, a genomics and proteomics-based research and diagnostics services company and Raybiotech, a leading USA-based global provider of ELISA and multiplex protein detection technologies, announced that they have entered into a commercial partnership to co-brand Sengenics’ flagship protein array platform, Immunome. Sengenics Commercial Director, Matthew Rawlings, said, “The Raybiotech-Sengenics relationship is a very exciting commercial […]
Venlo, The Netherlands – QIAGEN N.V. (”NASDAQ: QGEN; Frankfurt Prime Standard: QIA”) announced on 29 March 2016 that QIAGEN N.V had decided to make a conditional, voluntary public tender offer for the shares of Exiqon A/S in which the shareholders of Exiqon are offered a cash amount of DKK 18 for each share they hold […]
Jena/Eisfeld, – Analytik Jena AG is selling its Eisfeld site as of the end of April 30, 2016, to NOBLEX GmbH. NOBLEX GmbH is a subsidiary of the Frankfurt-based investment company VF Capital GmbH. A corresponding agreement was signed this past Friday by both companies. In addition to the business with optical consumer products under […]
Copenhagen, – Exiqon A/S (Nasdaq Copenhagen: “EXQ”) announced on behalf of QIAGEN N.V the submission of a takeover offer to buy the entire share capital of Exiqon A/S. The price offered is DKK 18.00 per share of nominal DKK 1.00. The offer is valid until 18 May 2016 at 23.59 (CET). Please find enclosed a […]
As a leader in advancing research in oncology, BioLegend is proud to announce our partnership with The Parker Institute for Cancer Immunotherapy, a consortium of leading companies, nonprofits, and cancer centers, all coming together to maximize immunotherapy’s unique potential to tranform all cancers into manageable diseases, saving millions of lives. The Parker Institute is an […]
BÜCHI Labortechnik AG has entered into an agreement to buy the flash chromatography and ELSD product lines from Grace Discovery Sciences. The transaction has been approved by the board of directors of Grace and BUCHI and was closed with immediate effect. As such the Reveleris® Flash Chromatography Systems, GraceResolv™ and Alltech® ELSD 3300 brands of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
